Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Detection of plasma autoantibodies to brain tissue in young children with and without autism spectrum disorders.

Rossi CC, Van de Water J, Rogers SJ, Amaral DG.

Brain Behav Immun. 2011 Aug;25(6):1123-35. doi: 10.1016/j.bbi.2011.02.011. Epub 2011 Mar 21.

2.

Detection of autoantibodies to neural cells of the cerebellum in the plasma of subjects with autism spectrum disorders.

Wills S, Cabanlit M, Bennett J, Ashwood P, Amaral DG, Van de Water J.

Brain Behav Immun. 2009 Jan;23(1):64-74. doi: 10.1016/j.bbi.2008.07.007. Epub 2008 Jul 30.

3.

Behavioral correlates of maternal antibody status among children with autism.

Braunschweig D, Duncanson P, Boyce R, Hansen R, Ashwood P, Pessah IN, Hertz-Picciotto I, Van de Water J.

J Autism Dev Disord. 2012 Jul;42(7):1435-45. doi: 10.1007/s10803-011-1378-7.

4.

Further characterization of autoantibodies to GABAergic neurons in the central nervous system produced by a subset of children with autism.

Wills S, Rossi CC, Bennett J, Martinez-CerdeƱo V, Ashwood P, Amaral DG, Van de Water J.

Mol Autism. 2011 Apr 26;2:5. doi: 10.1186/2040-2392-2-5.

5.

Anti-brain antibodies are associated with more severe cognitive and behavioral profiles in Italian children with Autism Spectrum Disorder.

Piras IS, Haapanen L, Napolioni V, Sacco R, Van de Water J, Persico AM.

Brain Behav Immun. 2014 May;38:91-9. doi: 10.1016/j.bbi.2013.12.020. Epub 2014 Jan 3.

6.

Maternal autoantibodies are associated with abnormal brain enlargement in a subgroup of children with autism spectrum disorder.

Nordahl CW, Braunschweig D, Iosif AM, Lee A, Rogers S, Ashwood P, Amaral DG, Van de Water J.

Brain Behav Immun. 2013 May;30:61-5. doi: 10.1016/j.bbi.2013.01.084. Epub 2013 Feb 8.

7.

Cerebral folate receptor autoantibodies in autism spectrum disorder.

Frye RE, Sequeira JM, Quadros EV, James SJ, Rossignol DA.

Mol Psychiatry. 2013 Mar;18(3):369-81. doi: 10.1038/mp.2011.175. Epub 2012 Jan 10.

8.

Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome.

Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah I, Van de Water J.

Brain Behav Immun. 2011 Jan;25(1):40-5. doi: 10.1016/j.bbi.2010.08.003. Epub 2010 Aug 10.

9.

Increased anti-phospholipid antibodies in autism spectrum disorders.

Careaga M, Hansen RL, Hertz-Piccotto I, Van de Water J, Ashwood P.

Mediators Inflamm. 2013;2013:935608. doi: 10.1155/2013/935608. Epub 2013 Sep 23.

10.

Autoantibodies to cerebellum in children with autism associate with behavior.

Goines P, Haapanen L, Boyce R, Duncanson P, Braunschweig D, Delwiche L, Hansen R, Hertz-Picciotto I, Ashwood P, Van de Water J.

Brain Behav Immun. 2011 Mar;25(3):514-23. doi: 10.1016/j.bbi.2010.11.017. Epub 2010 Dec 4.

11.

Prevalence of autism spectrum disorders--Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008.

Autism and Developmental Disabilities Monitoring Network Surveillance Year 2008 Principal Investigators; Centers for Disease Control and Prevention.

MMWR Surveill Summ. 2012 Mar 30;61(3):1-19.

12.

Brain-reactive IgG correlates with autoimmunity in mothers of a child with an autism spectrum disorder.

Brimberg L, Sadiq A, Gregersen PK, Diamond B.

Mol Psychiatry. 2013 Nov;18(11):1171-7. doi: 10.1038/mp.2013.101. Epub 2013 Aug 20.

PMID:
23958959
13.

Does parent report of behavior differ across ADOS-G classifications: analysis of scores from the CBCL and GARS.

Sikora DM, Hall TA, Hartley SL, Gerrard-Morris AE, Cagle S.

J Autism Dev Disord. 2008 Mar;38(3):440-8. Epub 2007 Jul 6.

PMID:
17619131
14.

Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, United States, 2006.

Autism and Developmental Disabilities Monitoring Network Surveillance Year 2006 Principal Investigators; Centers for Disease Control and Prevention (CDC).

MMWR Surveill Summ. 2009 Dec 18;58(10):1-20. Erratum in: MMWR Surveill Summ. 2010 Aug 6;59(30):956.

15.

Autoantibodies against neuronal progenitors in sera from children with autism.

Mazur-Kolecka B, Cohen IL, Gonzalez M, Jenkins EC, Kaczmarski W, Brown WT, Flory M, Frackowiak J.

Brain Dev. 2014 Apr;36(4):322-9. doi: 10.1016/j.braindev.2013.04.015. Epub 2013 Jul 6.

PMID:
23838310
16.

Brain-specific autoantibodies in the plasma of subjects with autistic spectrum disorder.

Cabanlit M, Wills S, Goines P, Ashwood P, Van de Water J.

Ann N Y Acad Sci. 2007 Jun;1107:92-103.

PMID:
17804536
17.

Autism-specific maternal anti-fetal brain autoantibodies are associated with metabolic conditions.

Krakowiak P, Walker CK, Tancredi D, Hertz-Picciotto I, Van de Water J.

Autism Res. 2017 Jan;10(1):89-98. doi: 10.1002/aur.1657. Epub 2016 Jun 17.

19.

Age- and sex-related emotional and behavioral problems in children with autism spectrum disorders: comparison with control children.

Horiuchi F, Oka Y, Uno H, Kawabe K, Okada F, Saito I, Tanigawa T, Ueno S.

Psychiatry Clin Neurosci. 2014 Jul;68(7):542-50. doi: 10.1111/pcn.12164. Epub 2014 Mar 11.

20.

Pathways underlying the gut-to-brain connection in autism spectrum disorders as future targets for disease management.

de Theije CG, Wu J, da Silva SL, Kamphuis PJ, Garssen J, Korte SM, Kraneveld AD.

Eur J Pharmacol. 2011 Sep;668 Suppl 1:S70-80. doi: 10.1016/j.ejphar.2011.07.013. Epub 2011 Jul 27. Review.

PMID:
21810417

Supplemental Content

Support Center